Based in Tampa, Florida, Virginia Pelley is a former women's magazine editor who has written health and fitness content for Men's Journal, Cosmopolitan magazine, the Chicago Tribune, ...
If you’re taking Strattera, you may wonder whether you need to avoid or limit certain foods. Strattera doesn’t interact with any foods, but taking it with certain foods may affect how well your body ...
The Food and Drugs Administration have approved Strattera and Vyvanse to treat attention deficit hyperactivity disorder in children and adults. Strattera (atomoxetine) and Vyvanse (lisdexamfetamine) ...
Strattera vs. Ritalin: What Is the Difference? Strattera and Ritalin are medicines that children and adults can take to manage symptoms of attention deficit hyperactivity disorder (ADHD). Both drugs ...
Strattera (atomoxetine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Strattera comes as an oral capsule. Strattera is used in adults and certain ...
Eli Lilly and Company announced today that it has added a warning to Strattera (search), an attention deficit hyperactivity disorder (ADHD) medication. Lilly says Strattera should be stopped in ...
Strattera is a non-stimulant medication for ADHD that works by increasing norepinephrine in your brain. Common side effects of Strattera include dry mouth, nausea, and reduced appetite. Stimulants ...
Eli Lilly and Company (NYSE: LLY) announced today that the United States Food and Drug Administration (FDA) has approved Strattera® (atomoxetine HCI) for ...
The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...
A not yet released discussion paper written by the British Medicines and Healthcare Regulatory Agency, reveals that last fall, there were 130 reports of suicidality in a single month by patients ...
Indianapolis-based Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, has won a court order extending the ban on generic versions of the attention-deficit treatment Strattera while it ...